Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 351–400 of 422 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06609863	dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma	recruiting	N/A	27	Sun Yat-sen UniversityOTHER	1	Dec 3, 2024	clinicaltrials
NCT06609876	Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC	recruiting	N/A	108	Sun Yat-sen UniversityOTHER	1	Dec 3, 2024	clinicaltrials
NCT05484908